An updated patent review of small-molecule c-Met kinase inhibitors (2018-present).

Chu, Cilong; Rao, Zixuan; Pan, Qingshan; Zhu, Wufu

Chu, Cilong; Rao, Zixuan; Pan, Qingshan; Zhu, Wufu.

Afiliación

Chu C; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.
Rao Z; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.
Pan Q; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.
Zhu W; Jiangxi Provincial Key Laboratory of Drug Design and Evaluation, School of Pharmacy, Jiangxi Science & Technology Normal University, Nanchang, Jiangxi, China.

Expert Opin Ther Pat ; 32(3): 279-298, 2022 Mar.

Article en En | MEDLINE | ID: mdl-34791961

Asunto(s)

Antineoplásicos; Neoplasias; Antineoplásicos/química; Humanos; Neoplasias/tratamiento farmacológico; Neoplasias/genética; Patentes como Asunto; Inhibidores de Proteínas Quinasas/química; Proteínas Proto-Oncogénicas c-met

Palabras clave

Cancer therapy; c-Met inhibitors; patent review; small-molecule inhibitor

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias / Antineoplásicos Límite: Humans Idioma: En Revista: Expert Opin Ther Pat Asunto de la revista: TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google